The shares of Ares Capital Corporation (NASDAQ:ARCC) started off the last trading session with the price of $15.92 while closing the day with the price of $15.9. The shares of Ares Capital Corporation (NASDAQ:ARCC) Rise 0.38% with the Loss of -0.02 points.
The shares of Ares Capital Corporation (NASDAQ:ARCC) traded with the day volume of 2.5 Million shares whereas its average trading volume is 2.14 Million.
While analyzing the past performance of the stock we can see that the shares of Ares Capital Corporation (NASDAQ:ARCC) Gain 1.21% in the last week while rising 0.89% in the last month. Past quarter performance shows the red light with -2.09%. The semi-annual and annual performance shows -0.38% and -9.71% respectively.
Some critical values of the shares of Ares Capital Corporation (NASDAQ:ARCC) to be discussed here are: the beta which shows the value at 0.67 while Average True Range of Ares Capital Corporation (NASDAQ:ARCC) demonstrate the value at 0.23. The weekly and monthly volatility of the shares of Ares Capital Corporation (NASDAQ:ARCC) are indicated at 1.15% and 1.41%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 51.67.
While studying the financial position of the shares of Ares Capital Corporation (NASDAQ:ARCC), we can see that the Market capitalization of the company is at 6.75 Billion. The shares outstanding for the company is 424.69 Million and the shares float stands at 424.44 Million. The income of the company stand at 667 Million while the sales stand at 1.16 Billion.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 1.57, Price to Earnings or P/E is at 10.13, Price to Sales P/S show the value of 5.82, the Return on Asset ROA stood at 0.055 and the Return on Equity ROE depicted at 0.095 while Return on Investment ROI is at 0.042.
Regulus Therapeutics Inc. (NASDAQ:RGLS)
Regulus Therapeutics Inc. (NASDAQ:RGLS) started its previous trading session at $0.9 and closed at $0.95 showing a Rise of 12.18 Percent.
The Company traded with an average Volume of 663.31 Million whereas, its Day Volume stood at 2.5 Million.
Looking at the performance of the stock, Regulus Therapeutics Inc. (NASDAQ:RGLS) Loss -19.66% in the last week in its shares price and -18.28% in the last month. Quarterly performance shows a green of 2.65 Percent while Semi-Annual and Annual performances shows a -9.71 and -24.16 percent respectively.
Beta for Regulus Therapeutics Inc. (NASDAQ:RGLS) stands at 1.47 while the ATR (average true range) is at 0.11. The Stock’s Weekly and Monthly Volatility is 14.73% and 9.91% respectively showing a RSI value of 39.12.
While studying the financial position of the shares of Regulus Therapeutics Inc. (NASDAQ:RGLS), we can see that the Market capitalization of the company is at 87.9 Million. The shares outstanding for the company is 92.72 Million and the shares float stands at 88.75 Million.
The Company generated an income of -71900000 and the sales of 70000 in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-1.1 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 1220.81 respectively.
The Return on Assets stands at -0.926, ROE shows a value of -2.018 and ROI for Regulus Therapeutics Inc. (NASDAQ:RGLS) is 0 as of Trailing Twelve Months period.
